🔎 Trials Near Me

Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › North Carolina › Charlotte

Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Charlotte, NC keessatti

Qorannoo 19 Kansara Qara'a Non-Small Cell f Charlotte fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Namoota walitti qabaa jiraSadarkaa 3
  • Novant Health Weisiger Cancer Insititute ( Site 0266), Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06623422

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Namoota walitti qabaa jiraSadarkaa 3
  • Carolinas Medical Center, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06765109

Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

Namoota walitti qabaa jiraSadarkaa 2
  • Levine Cancer Institute, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04253964

Pan-tumor MRD Study

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Carolina Oncology Specialists, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06605404

Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Atrium Health Levine Cancer, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05696782

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Carolina Biooncology Institute, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT05267626

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • Levine Cancer Institute, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07195695

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Carolina BioOncology Institute, LLC, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06750185

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

Namoota walitti qabaa jiraSadarkaa 1/2
  • Levine Cancer Institute - Charlotte, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06043817

Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Atrium Health Levine Cancer, Charlotte
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06567704

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Clinical Trial Site, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07749586

Study of XB010 in Subjects With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Carolina BioOncology Institute, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT06545331

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Carolina BioOncology Institute, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT06040541

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Carolina BioOncology Institute, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT05431270

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte
  • Atrium Health Pineville/LCI-Pineville, Charlotte
  • Levine Cancer Institute-SouthPark, Charlotte
  • fi 8 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06418204

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Carolina BioOncology Institute, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Gur-2026 · NCT07030257

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Namoota walitti qabaa jiraSadarkaa 1
  • Dren Investigational Site, Huntersville · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ama-2026 · NCT06999187

Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti

Qorannoo biroo Charlotte keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.